MANAGEMENT

Ed Pershing, CPA, Chief Executive Officer

Mr. Pershing has served as non-executive Chairman of our Board since 2018. He was the Chief Executive Officer of Pershing Yoakley & Associates (PYA), until November 2019 when he retired. PYA is a top 20 healthcare consulting and top 100 accounting firm in the U.S. PYA, which he co-founded more than 30 years ago, expanded from a three-employee office to more than 270 employees and five affiliate companies serving more than 3,500 clients in 50 states. Mr. Pershing’s healthcare experience and expertise include turnaround/performance improvement initiatives, long-range planning studies, development of numerous hospital and medical office projects, restructuring of healthcare organizations, liaison between boards of directors and management teams to craft corporate visions and strategies, mergers, acquisitions, divestitures, and leasing arrangements. He has served as an expert witness on healthcare industry matters and in several Certificate of Need appeals. Mr. Pershing also has represented healthcare organizations before regulatory agencies such as the Centers for Medicare & Medicaid Services, Internal Revenue Service, and Departments of Mental Health, Insurance, and Medicaid. He graduated from the University of Tennessee with a Bachelor of Science in Accounting and was one of eighteen professionals from the U.S. and Great Britain to participate in the first Ernst & Ernst Accelerated Healthcare Program, a one-year full-time education and work-study program in healthcare industry matters. Mr. Pershing is a Certified Public Accountant (CPA).

Dominic Rodrigues, President

Mr. Rodrigues has served as a member of our Board since 2017 and its non-executive Vice Chairman since 2018, previously serving as non-executive Chairman of our Board from 2017 to 2018. Mr. Rodrigues previously served as President of Rhisk Capital, where he did management consulting, corporate development, and portfolio management. Project industries and technologies included aerospace & defense (a technology-focused, private equity-styled, capital investment pool; corporate development and operational roles at a related data communications company), financial services (a capital markets-focused, financial technology start-up company; a start-up private wealth office), healthcare, life sciences, and nanotechnology (a venture capital-styled investment). Mr. Rodrigues also previously served as an Adjunct Professor of Finance at the Lee Business School of the University of Nevada, Las Vegas. His business development, corporate development, finance, operations, and leadership experiences at various companies include working as a corporate venture capitalist at SAIC Venture Capital Corporation (SAIC VCC), the multi-billion-dollar subsidiary of research and engineering company SAIC, where he was an observer or member of the board of directors of a number of SAIC VCC portfolio companies; a proprietary currency derivatives trader at Bank of Montreal, a Canadian multinational investment bank and financial services company; and a project manager and engineer at Jacques Whitford, a Canadian multinational environmental consulting company. He holds business, economics, and engineering degrees from The Wharton School, the London School of Economics, the Massachusetts Institute of Technology, and the University of Toronto.

Eric Wachter, Ph.D., Chief Technology Officer

Dr Wachter has served as our Chief Technology Officer since 2012. Dr. Wachter previously served as Executive Vice President, Pharmaceuticals and as a member of our Board from 2002 to 2012 and from 2016 to 2018. From 1997 to 2002, he was a senior member of the management team and a co-founder of Photogen Technologies, Provectus’ precursor company, including serving as Vice President, Secretary, and a member of its board of directors. Prior to joining Photogen, Dr. Wachter served as a senior research staff member with Oak Ridge National Laboratory (ORNL), where he conducted research and development of advanced nanosensor and remote sensor technologies in the environmental and biomedical sciences, as well as for defense and transportation applications. A holder of approximately 40 patents, his awards include an R&D 100 for nanosensors, an R&D 100 for laser metrology, the Inventor’s Forum Advanced Technology Award, the Excellence in Research Award from ORNL, and an Upjohn Fellowship. He earned a Ph.D. in Chemistry from the University of Wisconsin–Madison in 1988 and and a bachelor’s degree in chemistry from Indiana University-Bloomington.

Heather Raines, CPA, Chief Financial Officer

Mrs. Raines has served as our CFO since 2019. Mrs. Raines previously served as the Company’s Controller from 2017 until her appointment as the Company’s CFO. Before joining the Company, Mrs. Raines served as the Vice President of Finance for BDry Waterproofing, a service business, from 2015 to 2017. She previously managed financial and accounting functions at AMETEK, Inc. (NYSE: AME), a manufacturing company, serving as AMT Business Unit Controller for AMETEK’s wholly owned subsidiary, Advanced Measurement Technology, Inc., in 2015, Scientific Instruments Business Unit Controller from 2013 to 2015, and Senior Finance Manager from 2007 to 2013. Mrs. Raines was a tax analyst at Goody’s Family Clothing from 2006 to 2007, and an Accounting Manager at Siemens Medical Solutions USA, Inc., a wholly owned subsidiary of Siemens AG (NYSE: SI), from 2005 to 2006, and CTI Molecular Imaging, Inc. (Nasdaq: CTMI) from 1999 to 2005. Mrs. Raines received a Master’s Degree in Accounting from Strayer University and a Bachelor’s Degree in Accounting from the University of Tennessee. She is a CPA, and a member of the American Institute of CPAs, the Tennessee Society of CPAs, and the Institute of Management Accountants.